Rakovina Therapeutics Inc (RKV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 752 | 739 | 838 | 146 |
| Operating Income | -752 | -739 | -838 | -146 |
| Other Income | 0 | 2 | 3 | -3,052 |
| Pre-tax Income | -751 | -737 | -835 | -3,197 |
| Net Income Continuous | -751 | -737 | -835 | -3,197 |
| Net Income | $-751 | $-737 | $-835 | $-3,197 |
| EPS Basic Total Ops | 0.00 | -0.10 | -0.10 | -0.46 |
| EPS Basic Continuous Ops | 0.00 | -0.10 | -0.10 | N/A |
| EPS Diluted Total Ops | 0.00 | -0.10 | -0.10 | -0.46 |
| EPS Diluted Continuous Ops | 0.00 | -0.10 | -0.10 | N/A |
| EBITDA(a) | $-617 | $-604 | $-704 | $-137 |